STX1A - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-STX1A - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | STX1A - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | cow, dog, guinea pig, human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against STX1A. It was validated on Western Blot using a cell lysate as a positive control.Target Description: Synaptic vesicles store neurotransmitters that are released during calcium-regulated exocytosis. The specificity of neurotransmitter release requires the localization of both synaptic vesicles and calcium channels to the presynaptic active zone. Syntaxins function in this vesicle fusion process. Syntaxins also serve as a substrate for botulinum neurotoxin type C, a metalloprotease that blocks exocytosis and has high affinity for a molecular complex that includes the alpha-latrotoxin receptor which produces explosive exocytosis. Synaptic vesicles store neurotransmitters that are released d |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human STX1A |
| Other Names | [syntaxin-1A isoform 1; Syntaxin-1A; syntaxin-1A; syntaxin 1A; Neuron-specific antigen HPC-1] |
| Gene, Accession # | [STX1A], Gene ID: 6804, NCBI: NP_004594, UniProt: Q16623 |
| Catalog # | MBS3224521 |
| Price | $335 |
| Order / More Info | STX1A - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies